Genzyme Europe

Genzyme is a world-leading biotechnology company dedicated to discovering and delivering transformative therapies for patients with rare and specialized unmet medical needs. Genzyme has long been renowned for its expertise in a category of rare genetic diseases known as lysosomal storage disorders (LSD). Today, while LSD remains at the core of the company, they have also expanded into other disease areas such as thyroid cancer and multiple sclerosis through internal development, strategic acquisitions, and partnerships.